The multifaceted roles of TRAFs in the regulation of B-cell function (original) (raw)

• Lotz, M., Setareh, M., von Kempis, J. & Schwartz, H. The NGF/TNF receptor family. J. Leukoc. Biol. 60, 1–7 (1996).
  Article CAS PubMed Google Scholar
• Locksley, R. M., Kileen, N. & Lenardo, M. J. The TNF and TNFR superfamilies: integrating mammalian biology. Cell 104, 487–501 (2001).
  Article CAS PubMed Google Scholar
• Noelle, R. J., Ledbetter, J. A. & Aruffo, A. CD40 and its ligand, an essential ligand–receptor pair for thymus-dependent B-cell activation. Immunol. Today 13, 431–433 (1992).
  Article CAS PubMed Google Scholar
• Banchereau, J. et al. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12, 881–922 (1994).
  Article CAS PubMed Google Scholar
• Bishop, G. A. & Hostager, B. S. The CD40–CD154 interaction in B cell–T cell liaisons. Cytokine Growth Factor Rev. 14, 297–309 (2003).
  Article CAS PubMed Google Scholar
• Foy, T. M. et al. gp39–CD40 interactions are essential for germinal center formation and the development of B cell memory. J. Exp. Med. 180, 157–163 (1994).
  Article CAS PubMed Google Scholar
• Kawabe, T. et al. The immune responses in CD40-deficient mice: impaired Ig class switching and germinal center formation. Immunity 1, 167–178 (1994).
  Article CAS PubMed Google Scholar
• Rieckmann, P., D'Allessandro, F., Nordan, R. P., Fauci, A. S. & Kehrl, J. H. IL-6 and TNF-α. Autocrine and paracrine cytokines involved in B cell function. J. Immunol. 146, 3462–3468 (1991).
  CAS PubMed Google Scholar
• Gauchat, J. -F., Aversa, G., Gascan, H. & de Vries, J. E. Modulation of IL-4 induced germline ε RNA synthesis in human B cells by TNFα, anti-CD40 mAb or TGF-β correlates with levels of IgE production. Int. Immunol. 4, 397–406 (1992).
  Article CAS PubMed Google Scholar
• Macchia, D. et al. Membrane TNF-α is involved in the polyclonal B-cell activation induced by HIV-infected human T cells. Nature 363, 464–466 (1993).
  Article CAS PubMed Google Scholar
• Ranheim, E. A. & Kipps, T. J. TNF-α facilitates induction of CD80 (B7-1) and CD54 on human B cells by activated T cells: complex regulation by IL-4, IL-10, and CD40L. Cell. Immunol. 161, 226–235 (1995).
  Article CAS PubMed Google Scholar
• Worm, M. & Geha, R. S. Activation of TNF-α and lymphotoxin-β via anti-CD40 in human B cells. Int. Arch. Allergy Immunol. 107, 368–369 (1995).
  Article CAS PubMed Google Scholar
• Worm, M., Ebermayer, K. & Henz, B. Lymphotoxin-α is an important autocrine factor for CD40 + IL-4-mediated B cell activation in normal and atopic donors. Immunology 94, 395–402 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Hostager, B. S. & Bishop, G. A. Role of TRAF2 in the activation of IgM secretion by CD40 and CD120b. J. Immunol. 168, 3318–3322 (2002). This study exemplifies how a TRAF can have an indirect role in signalling to B cells by a TNFR-family member. TRAF2 is required for optimal CD40-mediated IgM production, but it does not need to directly interact with CD40. Instead, in B cells, CD40-induced TNF binds to CD120b, which requires the direct binding of TRAF2 for signalling.
  Article CAS PubMed Google Scholar
• Klein, U., Rajewsky, K. & Küppers, R. Human IgM+IgD+ peripheral blood B cells expressing the CD27 surface antigen carry somatically mutated variable region genes: CD27 as a general marker for somatically mutated (memory) B cells. J. Exp. Med. 188, 1679–1689 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Agematsu, K., Hokibara, S., Nagumo, H. & Komiyama, A. CD27: a memory B cell marker. Immunol. Today 21, 204–206 (2000).
  Article CAS PubMed Google Scholar
• Morimoto, S. et al. CD134L engagement enhances human B cell Ig production: CD154/CD40, CD70/CD27, and CD134/CD134L interactions coordinately regulate T cell-dependent B cell responses. J. Immunol. 164, 4097–4104 (2000).
  Article CAS PubMed Google Scholar
• Nagumo, H. et al. CD27/CD70 interaction augments IgE secretion by promoting the differentiation of memory B cells into plasma cells. J. Immunol. 161, 6496–6502 (1998).
  CAS PubMed Google Scholar
• Jacquot, S., Kobata, T., Iwata, S., Morimoto, C. & Schlossman, S. F. CD154/CD40 and CD70/CD27 interactions have different and sequential functions in T cell-dependent B cell responses. J. Immunol. 159, 2652–2657 (1997).
  CAS PubMed Google Scholar
• Jumper, M. D., Fujita, K., Lipsky, P. E. & Meek, K. A CD30 responsive element in the germline ε promoter that is distinct from and inhibitory to the CD40 response element. Mol. Immunol. 33, 965–972 (1996).
  Article CAS PubMed Google Scholar
• Cerutti, A. et al. CD30 is a CD40-inducible molecule that negatively regulates CD40-mediated Ig class switching in non-antigen-selected human B cells. Immunity 9, 247–256 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Cerutti, A. et al. Engagement of CD153 by CD30+ T cells inhibits class switch DNA recombination and antibody production in human IgD+IgM+ B cells. J. Immunol. 165, 786–794 (2000).
  Article CAS PubMed Google Scholar
• Baker, S. J. & Reddy, E. P. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 12, 1–9 (1996).
  CAS PubMed Google Scholar
• Do, R. K. G. & Chen-Kiang, S. Mechanisms of BLyS action in B cell immunity. Cytokine Growth Factor Rev. 13, 19–25 (2002).
  Article CAS PubMed Google Scholar
• Arch, R. H., Gedrich, R. W. & Thompson, C. B. TRAFs — a family of adapter proteins that regulates life and death. Genes Dev. 12, 2821–2830 (1998).
  Article CAS PubMed Google Scholar
• Chan, F. K., Siegel, R. M. & Lenardo, M. J. Signaling by the TNF receptor superfamily and T cell homeostasis. Immunity 13, 419–422 (2000).
  Article CAS PubMed Google Scholar
• Bishop, G. A., Hostager, B. S. & Brown, K. D. Mechanisms of tumor necrosis factor receptor associated factor (TRAF) regulation in B lymphocytes. J. Leukoc. Biol. 72, 19–23 (2002).
  CAS PubMed Google Scholar
• Akira, S. TLR signaling. J. Biol. Chem. 278, 38105–38108 (2003).
  Article CAS PubMed Google Scholar
• McWhirter, S. M. et al. Crystallographic analysis of CD40 recognition and signaling by human TRAF2. Proc. Natl Acad. Sci. USA 96, 8408–8413 (1999). This is the first report of a crystal structure of the TRAF-binding portion of CD40 and the CD40-binding portion of TRAF2.
  Article CAS PubMed PubMed Central Google Scholar
• Ni, C. et al. Molecular basis for CD40 signaling mediated by TRAF3. Proc. Natl Acad. Sci. USA 97, 10395–10399 (2000). This paper shows a crystal structure that has the advantage of using the entire CD40 cytoplasmic domain. It reveals that, although there is overlap between the CD40-binding sites of TRAF2 and TRAF3, TRAF3 associates with CD40 in a different manner than TRAF2.
  Article CAS PubMed PubMed Central Google Scholar
• Chan, F. K. et al. A domain in TNF receptors that mediates ligand-independent receptor assembly and signaling. Science 288, 2351–2354 (2000).
  Article CAS PubMed Google Scholar
• Hostager, B. S., Catlett, I. M. & Bishop, G. A. Recruitment of CD40, TRAF2 and TRAF3 to membrane microdomains during CD40 signaling. J. Biol. Chem. 275, 15392–15398 (2000). This report provides the first evidence that engagement of a TNFR-family member endogenously expressed by B cells can recruit associated TRAFs to lipid rafts.
  Article CAS PubMed Google Scholar
• Kuhné, M. R. et al. Assembly and regulation of the CD40 receptor complex in human B cells. J. Exp. Med. 186, 337–342 (1997). This is the first report to show that, in B cells, endogenous TRAFs show little association with CD40 until CD40 is engaged by its ligand. After this occurs, TRAF2 and TRAF3 are rapidly recruited to the receptor complex at the cell-surface.
  Article PubMed PubMed Central Google Scholar
• Bishop, G. A. & Hostager, B. S. B lymphocyte activation by contact-mediated interactions with T lymphocytes. Curr. Opin. Immunol. 13, 278–285 (2001).
  Article CAS PubMed Google Scholar
• Huang, D. C. S. et al. Activation of Fas by FasL induces apoptosis by a mechanism that cannot be blocked by Bcl-2 or Bcl-xL . Proc. Natl Acad. Sci. USA 96, 14871–14876 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Baccam, M. & Bishop, G. A. Membrane-bound CD154, but not anti-CD40 mAbs, induces NF-κB independent B cell IL-6 production. Eur. J. Immunol. 29, 3855–3866 (1999).
  Article CAS PubMed Google Scholar
• Baccam, M., Woo, S., Vinson, C. & Bishop, G. A. CD40-mediated transcriptional regulation of the IL-6 gene in B lymphocytes: involvement of NF-κB, AP-1, and C/EBP. J. Immunol. 170, 3099–3108 (2003).
  Article CAS PubMed Google Scholar
• Rush, J. S. & Hodgkin, P. D. B cells activated via CD40 and IL-4 undergo a division burst but require continued stimulation to maintain division, survival and differentiation. Eur. J. Immunol. 31, 1150–1159 (2001).
  Article CAS PubMed Google Scholar
• Lee, B. O., Haynes, L., Eaton, S. M., Swain, S. L. & Randall, T. D. The biological outcome of CD40 signaling is dependent on the duration of CD40L expression: reciprocal regulation by IL-4 and IL-12. J. Exp. Med. 196, 693–704 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Jalukar, S. V., Hostager, B. S. & Bishop, G. A. Characterization of the roles of TRAF6 in CD40-mediated B lymphocyte effector functions. J. Immunol. 164, 623–630 (2000).
  Article CAS PubMed Google Scholar
• Polyak, M. J., Tailor, S. H. & Deans, J. P. Identification of a cytoplasmic region of CD20 required for its redistribution to a detergent insoluble membrane compartment. J. Immunol. 161, 3242–3248 (1998).
  CAS PubMed Google Scholar
• Cheng, P. C., Dykstra, M. L., Mitchell, R. N. & Pierce, S. K. A role for lipid rafts in B cell antigen receptor signaling and antigen targeting. J. Exp. Med. 190, 1549–1560 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Bouillon, M. et al. Lipid raft-dependent and independent signaling through HLA-DR molecules. J. Biol. Chem. 278, 7099–7107 (2003).
  Article CAS PubMed Google Scholar
• Ardila-Osorio, H. et al. Evidence of LMP1–TRAF3 interactions in glycosphingolipid-rich complexes of lymphoblastoid and nasopharyngeal carcinoma cells. Int. J. Cancer 81, 645–649 (1999).
  Article CAS PubMed Google Scholar
• Cottin, V., Doan, J. E. S. & Riches, D. W. H. Restricted localization of the TNF-R CD120a to lipid rafts: a novel role for the death domain. J. Immunol. 168, 4095–4102 (2002).
  Article CAS PubMed Google Scholar
• Arron, J. R., Pewzner-Jung, Y., Walsh, M. C., Kobayashi, T. & Choi, Y. Regulation of the subcellular localization of TRAF2 by TRAF1 reveals mechanisms of TRAF2 signaling. J. Exp. Med. 196, 923–934 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Hueber, A. -O., Bernard, A. -M., Hérincs, Z., Couzinet, A. & He, H. -T. An essential role for membrane rafts in the initiation of Fas/CD95-triggered cell death in mouse thymocytes. EMBO Rep. 3, 1–7 (2002).
  Article Google Scholar
• Ha, H. et al. Membrane rafts play a crucial role in RANK signaling and osteoclast function. J. Biol. Chem. 278, 18573–18580 (2003).
  Article CAS PubMed Google Scholar
• Ye, H., Park, Y. C., Kreishman, M., Kieff, E. & Wu, H. The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol. Cell 4, 321–330 (1999).
  Article CAS PubMed Google Scholar
• Rothe, M., Sarma, V., Dixit, V. M. & Goeddel, D. V. TRAF2-mediated activation of NF-κB by TNF receptor 2 and CD40. Science 269, 1424–1427 (1995).
  Article CAS PubMed Google Scholar
• Pullen, S. S. et al. CD40–TRAF interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization. Biochemistry 37, 11836–11845 (1998).
  Article CAS PubMed Google Scholar
• Haxhinasto, S. A. & Bishop, G. A. A novel interaction between PKD and TRAFs regulates BCR–CD40 synergy. J. Immunol. 171, 4655–4662 (2003).
  Article CAS PubMed Google Scholar
• Haxhinasto, S. A. & Bishop, G. A. Synergistic B cell activation by CD40 and the BCR: role of BCR-mediated kinase activation and TRAF regulation. J. Biol. Chem. 279, 2575–2582 (2004).
  Article CAS PubMed Google Scholar
• Horejsí, V. et al. GPI-microdomains: a role in signalling via immunoreceptors. Immunol. Today 20, 356–361 (1999).
  Article PubMed Google Scholar
• Rudd, C. E. Adaptors and molecular scaffolds in immune cell signaling. Cell 96, 5–8 (1999).
  Article CAS PubMed Google Scholar
• Aggarwal, B. B. Signalling pathways of the TNF superfamily: a double-edged sword. Nature Rev. Immunol. 3, 745–756 (2003).
  Article CAS Google Scholar
• Duckett, C. S. & Thompson, C. B. CD30-dependent degradation of TRAF2: implications for negative regulation of TRAF signaling and the control of cell survival. Genes Dev. 11, 2810–2821 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Brown, K. D., Hostager, B. S. & Bishop, G. A. Differential signaling and TRAF degradation by CD40 and the EBV oncoprotein LMP1. J. Exp. Med. 193, 943–954 (2001). This paper shows that CD40-mediated signalling induces rapid proteasome-dependent degradation of TRAF2 and TRAF3. By contrast, the sustained and amplified signalling to B cells that is provided by the CD40 mimic LMP1 correlates with a failure of LMP1 to promote degradation of associated TRAF2 and TRAF3.
  Article CAS PubMed PubMed Central Google Scholar
• Takayanagi, H. et al. T-cell mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-γ. Nature 408, 600–605 (2000).
  Article CAS PubMed Google Scholar
• Brown, K. D., Hostager, B. S. & Bishop, G. A. Regulation of TRAF2 signaling by self-induced degradation. J. Biol. Chem. 277, 19433–19438 (2002).
  Article CAS PubMed Google Scholar
• Hostager, B. S., Haxhinasto, S. A., Rowland, S. R. & Bishop, G. A. TRAF2-deficient B lymphocytes reveal novel roles for TRAF2 in CD40 signaling. J. Biol. Chem. 278, 45382–45390 (2003). This study uses a new method of gene targeting by homologous recombination to produce B-cell lines from several genetic backgrounds that lack TRAF2. Experiments using these cells show that, in B cells, TRAF2 has overlapping roles with TRAF6 in NF-κB activation, as well as unique roles in TRAF3 degradation, JNK activation and CD40–BCR synergy.
  Article CAS PubMed Google Scholar
• Freemont, P. S. Ubiquitination: RING for destruction? Curr. Biol. 10, R84–R87 (2000).
  Article CAS PubMed Google Scholar
• Moore, C. & Bishop, G. A. Receptor-induced TRAF degradation in B lymphocytes. FASEB J. 18, A428 (2004).
  Article CAS Google Scholar
• Ishida, T. et al. Identification of TRAF6, a novel TRAF protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region. J. Biol. Chem. 271, 28745–28748 (1996).
  Article CAS PubMed Google Scholar
• Yeh, W. et al. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7, 715–725 (1997).
  Article CAS PubMed Google Scholar
• Hsing, Y., Hostager, B. S. & Bishop, G. A. Characterization of CD40 signaling determinants regulating NF-κB activation in lymphocytes. J. Immunol. 159, 4898–4906 (1997).
  CAS PubMed Google Scholar
• Lomaga, M. A. et al. TRAF6 deficiency results in osteopetrosis and defective IL-1, CD40, and LPS signaling. Genes Dev. 13, 1015–1021 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Yasui, T. et al. Dissection of B cell differentiation during primary immune responses in mice with altered CD40 signals. Int. Immunol. 14, 319–329 (2002).
  Article CAS PubMed Google Scholar
• Ahonen, C. L. et al. The CD40–TRAF6 axis controls affinity maturation and the generation of long-lived plasma cells. Nature Immunol. 3, 451–456 (2002).
  Article CAS Google Scholar
• Jabara, H. H. et al. The binding site for TRAF2 and TRAF3 but not for TRAF6 is essential for CD40-mediated Ig class switching. Immunity 17, 265–276 (2002).
  Article CAS PubMed Google Scholar
• Haxhinasto, S. A., Hostager, B. S. & Bishop, G. A. Molecular mechanisms of synergy between CD40 and the BCR: role for TRAF2 in receptor interaction. J. Immunol. 169, 1145–1149 (2002).
  Article CAS PubMed Google Scholar
• Inui, S. et al. Identification of the intracytoplasmic region essential for signal transduction through a B cell activation molecule, CD40. Eur. J. Immunol. 20, 1747–1753 (1990).
  Article CAS PubMed Google Scholar
• Goldstein, M. D. & Watts, T. H. Identification of distinct domains in CD40 involved in B7-1 induction or growth inhibition. J. Immunol. 157, 2837–2843 (1996).
  CAS PubMed Google Scholar
• Hostager, B. S., Hsing, Y., Harms, D. E. & Bishop, G. A. Different CD40-mediated signaling events require distinct CD40 structural features. J. Immunol. 157, 1047–1053 (1996).
  CAS PubMed Google Scholar
• Sutherland, C. L., Krebs, D. L. & Gold, M. R. An 11-amino acid sequence in the cytoplasmic domain of CD40 is sufficient for activation of JNK, activation of MAPKAP kinase-2, phosphorylation of IκBα, and protection of WEHI-231 cells from anti-IgM-induced growth arrest. J. Immunol. 162, 4720–4730 (1999).
  CAS PubMed Google Scholar
• Lu, L., Cook, W. J., Lin, L. & Noelle, R. J. CD40 signaling through a newly identified TRAF2 binding site. J. Biol. Chem. 278, 45414–45418 (2003).
  Article CAS PubMed Google Scholar
• Xie, P., Hostager, B. S. & Bishop, G. A. Requirement for TRAF3 in signaling by LMP1, but not CD40, in B lymphocytes. J. Exp. Med. 199, 661–671 (2004). Using newly produced TRAF3-deficient B-cell lines, this paper presents the unexpected finding that TRAF3 has divergent roles in B-cell signalling mediated by different molecules: it inhibits CD40-mediated signalling, but it is an essential component of the B-cell activation mediated by LMP1.
  Article CAS PubMed PubMed Central Google Scholar
• Hsing, Y. & Bishop, G. A. Requirement for NF-κB activation by a distinct subset of CD40-mediated effector functions in B lymphocytes. J. Immunol. 162, 2804–2811 (1999).
  CAS PubMed Google Scholar
• Baud, V. et al. Signaling by proinflammatory cytokines: oligomerization of TRAF2 and TRAF6 is sufficient for JNK and IKK activation and target gene induction via an amino-terminal effector domain. Genes Dev. 13, 1297–1308 (1999).
  Article CAS PubMed PubMed Central Google Scholar
• Hostager, B. S. & Bishop, G. A. Contrasting roles of TRAF2 and TRAF3 in CD40-mediated B lymphocyte activation. J. Immunol. 162, 6307–6311 (1999).
  CAS PubMed Google Scholar
• Bishop, G. A. et al. Molecular mechanisms of B lymphocyte activation by the immune response modifier R-848. J. Immunol. 165, 5552–5557 (2000).
  Article CAS PubMed Google Scholar
• Bishop, G. A. et al. The immune response modifier, resiquimod, mimics CD40-induced B cell activation. Cell. Immunol. 208, 9–17 (2001).
  Article CAS PubMed Google Scholar
• Rothe, M., Wong, S. C., Henzel, W. J. & Goeddel, D. V. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 78, 681–692 (1994). In this report, the first two TRAFs are described and both are shown to associate with CD120b.
  Article CAS PubMed Google Scholar
• Devernge, O. et al. Association of TRAF1, TRAF2, and TRAF3 with an EBV LMP1 domain important for B-lymphocyte transformation: role in NF-κB activation. Mol. Cell. Biol. 16, 7098–7108 (1996).
  Article Google Scholar
• Pullen, S. S., Dang, T. T. A., Crute, J. J. & Kehry, M. R. CD40 signaling through TRAFs. Binding site specificity and activation of downstream pathways by distinct TRAFs. J. Biol. Chem. 274, 14246–14254 (1999). This paper presents a complete in vitro study of CD40-derived peptides binding to TRAFs produced by insect cells. Some CD40 mutants are subsequently studied in overexpression systems in HEK293 cells. The paper contains useful information; however, in B cells, not all CD40 mutants bind TRAFs in the way that is described here (for example, see reference 71), indicating cell-type specificity in some aspects of TRAF–receptor binding.
  Article CAS PubMed Google Scholar
• Carpentier, I. & Beyaert, R. TRAF1 is a TNF inducible regulator of NF-κB activation. FEBS Lett. 460, 246–250 (1999).
  Article CAS PubMed Google Scholar
• Leo, E. et al. TRAF1 is a substrate of caspases activated during TNF-α-induced apoptosis. J. Biol. Chem. 276, 8087–8093 (2001).
  Article CAS PubMed Google Scholar
• Fotin-Mleczek, M. et al. TRAF1 regulates CD40-induced TRAF2-mediated NF-κB activation. J. Biol. Chem. 279, 677–685 (2004).
  Article CAS PubMed Google Scholar
• Song, H. Y., Rothe, M. & Goeddel, D. V. The TNF-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-κB activation. Proc. Natl Acad. Sci. USA 93, 6721–6725 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Rothe, M., Pan, M., Henzel, W. J., Ayres, T. M. & Goeddel, D. V. The TNFR2–TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins. Cell 83, 1243–1252 (1995).
  Article CAS PubMed Google Scholar
• Duckett, C. S., Gedrich, R. W., Gilfillan, M. C. & Thompson, C. B. Induction of NF-κB by the CD30 receptor is mediated by TRAF1 and TRAF2. Mol. Cell. Biol. 17, 1535–1542 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Cha, G. -H. et al. Discrete functions of TRAF1 and TRAF2 in Drosophila melanogaster mediated by JNK and NF-κB-dependent signaling pathways. Mol. Cell. Biol. 23, 7982–7991 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Tsitsikov, E. et al. TRAF1 is a negative regulator of TNF signaling: enhanced TNF signaling in TRAF1-deficient mice. Immunity 15, 647–657 (2001).
  Article CAS PubMed Google Scholar
• Kilger, E., Kieser, A., Baumann, M. & Hammerschmidt, W. EBV-mediated B cell proliferation is dependent upon LMP1, which simulates an activated CD40 receptor. EMBO J. 17, 1700–1709 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Busch, L. K. & Bishop, G. A. The EBV transforming protein, LMP1, mimics and cooperates with CD40 signaling in B lymphocytes. J. Immunol. 162, 2555–2561 (1999).
  CAS PubMed Google Scholar
• Izumi, K. M., Kaye, K. M. & Kieff, E. D. The EBV LMP1 amino acid sequence that engages TRAFs is critical for primary B lymphocyte growth transformation. Proc. Natl Acad. Sci. USA 94, 1447–1452 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Busch, L. K. & Bishop, G. A. Multiple carboxyl-terminal regions of the EBV oncoprotein, LMP1, cooperatively regulate signaling to B lymphocytes via TRAF-dependent and TRAF-independent mechanisms. J. Immunol. 167, 5805–5813 (2001).
  Article CAS PubMed Google Scholar
• Kaye, K. M. et al. TRAF2 is a mediator of NF-κB activation by LMP1, the EBV transforming protein. Proc. Natl Acad. Sci. USA 93, 11085–11090 (1996).
  Article CAS PubMed PubMed Central Google Scholar
• Munroe, M. E. & Bishop, G. A. Differences in signaling mechanisms to B lymphocytes by CD40 and TNFR2 (CD120b). FASEB J. 18, A50 (2004).
  Google Scholar
• Berberich, I., Shu, G. L. & Clark, E. A. Cross-linking CD40 on B cells rapidly activates nuclear factor-κB. J. Immunol. 153, 4357–4366 (1994).
  CAS PubMed Google Scholar
• Coope, H. J. et al. CD40 regulates the processing of NF-κB2 p100 to p52. EMBO J. 21, 5375–5385 (2002).
  Article CAS PubMed PubMed Central Google Scholar
• Zarnegar, B. et al. Unique CD40-mediated biological program in B cell activation requires both type 1 and type 2 NF-κB activation pathways. Proc. Natl Acad. Sci. USA 101, 8108–8113 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Ren, C. L., Morio, T., Fu, S. M. & Geha, R. S. Signal transduction via CD40 involves activation of lyn kinase and phosphatidylinositol-3-kinase, and phosphorylation of phospholipase Cγ2. J. Exp. Med. 179, 673–680 (1994).
  Article CAS PubMed Google Scholar
• Zhu, N. et al. CD40 signaling in B cells regulates the expression of the Pim-1 kinase via the NF-κB pathway. J. Immunol. 168, 744–754 (2002).
  Article CAS PubMed Google Scholar
• Chin, A. I. et al. TANK potentiates TRAF-mediated JNK/SAPK activation through the GCK pathway. Mol. Cell. Biol. 19, 6665–6672 (1999). This is one of the rare studies that verifies interactions between TRAFs and downstream kinases that are expressed at normal levels in B cells. It shows that GC kinase is a probable intermediate between TRAF2 and the TRAF2-dependent activation of JNK.
  Article CAS PubMed PubMed Central Google Scholar
• Shi, C., Leonardi, A., Kyriakis, J., Siebenlist, U. & Kehrl, J. H. TNF-mediated activation of the SAPK pathway: TRAF2 recruits and activates germinal center kinase related. J. Immunol. 163, 3279–3285 (1999).
  CAS PubMed Google Scholar
• Yan, M. et al. Activation of SAPK by MEKK1 phosphorylation of its activator SEK1. Nature 372, 798–800 (1994).
  Article CAS PubMed Google Scholar
• Sanchez, I. et al. Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 372, 794–798 (1994).
  Article CAS PubMed Google Scholar
• Ichijo, H. et al. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways. Science 275, 90–94 (1997).
  Article CAS PubMed Google Scholar
• Malinin, N. L., Boldin, M. P., Kovalenko, A. V. & Wallach, D. MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature 385, 540–544 (1997).
  Article CAS PubMed Google Scholar
• Song, H. Y., Ré;gnier, C. H., Kirschning, C. J., Goeddel, D. V. & Rothe, M. TNF-mediated kinase cascades: bifurcation of NF-κB and JNK/SAPK pathways at TRAF2. Proc. Natl Acad. Sci. USA 94, 9792–9796 (1997).
  Article CAS PubMed PubMed Central Google Scholar
• Ling, L., Cao, Z. & Goeddel, D. V. NF-κB inducing kinase activates IKK-α by phosphorylation of Ser-176. Proc. Natl Acad. Sci. USA 95, 3792–3797 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Shinkura, R. et al. Alymphoplasia is caused by a point mutation in the mouse gene encoding NIK. Nature Genet. 22, 74–77 (1999).
  Article CAS PubMed Google Scholar
• Yamada, T. et al. Abnormal immune function of hemopoietic cells from aly mice, a natural strain with mutant NIK. J. Immunol. 165, 804–812 (2000).
  Article CAS PubMed Google Scholar
• Garceau, N. et al. Lineage-restriced function of NIK in transducing signals via CD40. J. Exp. Med. 191, 381–385 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Yin, L. et al. Defective LT-β receptor-induced NF-κB transcriptional activity in NIK-deficient mice. Science 291, 2162–2165 (2001).
  Article CAS PubMed Google Scholar
• Lee, F. S., Hagler, J., Chen, Z. J. & Maniatis, T. Activation of the IκBα kinase complex by MEKK1, a kinase of the JNK pathway. Cell 88, 213–222 (1997).
  Article CAS PubMed Google Scholar
• Bishop, G. A., Haxhinasto, S. A., Stunz, L. L. & Hostager, B. S. Antigen-specific B lymphocyte activation. CRC Crit. Rev. Immunol. 23, 149–197 (2003).
  Article CAS Google Scholar
• Mann, J., Oakley, F., Johnson, P. W. & Mann, D. A. CD40 induces interleukin-6 gene transcription in dendritic cells: regulation by TRAF2, AP-1, NF-κB and CBF1. J. Biol. Chem. 277, 17125–17138 (2002).
  Article CAS PubMed Google Scholar
• Huang, C. J., Chen, C. Y., Chen, H. H., Tsai, S. F. & Choo, K. B. TDPOZ, a family of bipartite animal and plant proteins that contain the TRAF (TD) and POZ/BTB domains. Gene 324, 117–127 (2004).
  Article CAS PubMed Google Scholar
• Hu, H. M., O'Rourke, K., Boguski, M. S. & Dixit, V. M. A novel RING finger protein interacts with the cytoplasmic domain of CD40. J. Biol. Chem. 269, 30069–30072 (1994).
  CAS PubMed Google Scholar
• Cheng, G. et al. Involvement of CRAF1, a relative of TRAF, in CD40 signaling. Science 267, 1494–1498 (1995).
  Article CAS PubMed Google Scholar
• Régnier, C. H. et al. Presence of a new conserved domain in CART1, a novel member of the TRAF protein family, which is expressed in breast carcinoma. J. Biol. Chem. 270, 25715–25721 (1995).
  Article PubMed Google Scholar
• Masson, R. et al. TRAF4 expression pattern during mouse development. Mech. Dev. 71, 187–191 (1998).
  Article CAS PubMed Google Scholar
• Shiels, H. et al. TRAF4 deficiency leads to tracheal malformation with resulting alterations in air flow to lungs. Am. J. Pathol. 157, 679–688 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Nakano, H. et al. TRAF5, an activator of NF-κB and putative signal transducer for the LT-β receptor. J. Biol. Chem. 271, 14661–14664 (1996).
  Article CAS PubMed Google Scholar
• Ishida, T. et al. TRAF5, a novel TNF-R-associated factor family protein, mediates CD40 signaling. Proc. Natl Acad. Sci. USA 93, 9437–9442 (1996).
  Article CAS PubMed PubMed Central Google Scholar